You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Persistence of Beta-Blocker Treatment After a Heart Attack

The percentage of patients 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of acute myocardial infarction (AMI) and who were prescribed persistent beta-blocker treatment for six months after discharge.

Date Reviewed: November 19, 2017

Measure Info

MIPS 442NQF 0071CMS 442NQF EndorsedCQMC Core Measure
Measure Type: 
Intermediate Outcome
Measure Steward: 
National Committee for Quality Assurance
Clinical Topic Area: 
Myocardial Infarction

Care Setting: 
Outpatient
Data Source: 
Claims
Electronic Health Records
Registry

ACP supports QPP measure 442: "Persistence of Beta-Blocker Treatment after a Heart Attack." The exclusion criterion is broad and it is appropriate to attribute the measure outcomes to the individual clinician. Additionally, the measure is based on high-quality evidence from the most recent recommendations of various organizations (*ACP, ACC, ACCF/AHA, ESC). While we support this measure, we note the measure is close to being topped out. Data from the 2014 HEDIS reporting period demonstrates an 84% compliance rate.

*American College of Physicians, American College of Cardiology, American College of Cardiology Foundation/American Heart Association, European Society of Cardiology

As part of an ongoing effort to improve user experience, we have made some updates to the Performance Measures section of ACP. Tell us what you think!